The United States of America as Represented by the Department of Veterans Affairs - Washington DC
International Classification:
A61K 35/28 A61K 35/26 A01N 25/00
US Classification:
424577, 514885
Abstract:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
The United States of America as represented by the Department of Vetrans Affairs - Washington DC
International Classification:
A61K 35/28 A61K 35/26 A01N 25/00
US Classification:
424577, 514885
Abstract:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
Methods And Compositions Using Cellular Asialodeterminants And Glycoconjugates For Targeting Cells To Tissues And Organs
Department of Veterans Affairs, Rehabilitation R&D Service - Baltimore MD
International Classification:
A61K 38/17 A61K 48/00 A61K 35/14
US Classification:
424093210, 424093700, 514008000
Abstract:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering lymphoid cells such as natural killer (NK) cells activated with interleukin-2 (IL-2), lymphokine-activated killer (LAK) cells and/or tumor-infiltrating lymphocytes (TILs) and/or cytotoxic lymphocytes (CTLs), or stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
Methods And Compositions For Mobilizing Stem Cells
Catherine Phillips - Amarillo TX, US Julian Breillatt - , US
International Classification:
A61K 38/19
US Classification:
424085100, 514008000
Abstract:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
Methods And Compositions For Directing Stem Cells To The Heart
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
Methods And Compositions For Directing Stem Cells To The Liver
Catherine Phillips - Amarillo TX, US Julian Breillatt - , US
International Classification:
A61K 35/28
US Classification:
424093700
Abstract:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
Methods And Compositions For Administering Stem Cells
Catherine Phillips - Amarillo TX, US Julian Breillatt - , US
International Classification:
A61K 45/00 A61K 31/739 A61K 38/17
US Classification:
424093700, 514054000, 514008000
Abstract:
The present invention is directed to methods for delivering cells to a target tissue in a mammal using glycoconjugate to traffic the cell to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
The present invention is directed to methods for delivering stem cells to a target tissue in a mammal using glycoconjugate to traffic the stem cells to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal.
Jul 2012 to 2000 Quality Control AnalystVALIC, Osage Amarillo, TX Nov 2009 to Jul 2012 Team MemberTexas Tech University Lubbock, TX Jan 2004 to Dec 2005 Graduate research AssistantAsian Development Bank
Jan 2002 to Dec 2003 Local Technical ConsultantUSAID-Development Alternatives, Inc
Jul 1998 to Dec 2001 Research Associate
Education:
Texas Tech University Lubbock, TX 2005 Master of Science in Agricultural EconomicsUniversity of the Philippines at Los Baos 1990 Bachelor of Science in StatisticsWest Texas A&M University Amarillo, TX 2012 Master of Business Administration in Computer Information System
UMass Memorial Medical GroupUniversity Of Massachusetts Memorial Medical Center Neurology 55 Lk Ave N Lvl A, Worcester, MA 01655 5088562527 (phone), 5088566778 (fax)
Education:
Medical School University of California, San Francisco School of Medicine Graduated: 1983
Procedures:
Lumbar Puncture Sleep and EEG Testing Neurological Testing
Dr. Phillips graduated from the University of California, San Francisco School of Medicine in 1983. She works in Worcester, MA and specializes in Neurology. Dr. Phillips is affiliated with HealthAlliance Hospital Leominster and UMASS Memorial Medical Center.
Dr. Phillips graduated from the Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2010. She works in Oxford, MS and specializes in Pediatrics. Dr. Phillips is affiliated with Baptist Memorial Hospital North Mississippi.
Ms. Phillips works in Mankato, MN and 2 other locations and specializes in Family Medicine. Ms. Phillips is affiliated with Mayo Clinic Health System Mankato and Ridgeview Sibley Medical Center.
Darwin Honda Owner & General Manager of the Sapphire Motor Group in Darwin Australia. Sapphire Motor Group includes Darwin Honda & Sapphire Motors Volkswagen.